Our Services
Medical Information
Helpful Resources
Published on: 5/6/2026
NAD+ therapy may help address chronic fatigue syndrome (CFS) by targeting mitochondrial dysfunction and oxidative stress. By boosting cellular NAD+ levels, this treatment supports energy production, DNA repair, and inflammation regulation—key factors in CFS symptom relief.
Doctors may recommend IV NAD+ infusions or oral precursors (like NR or NMN) based on your lab markers, symptom severity, and lifestyle. Patients often report improvements in stamina, mental clarity, and sleep quality. Below, you'll find detailed guidance on dosing protocols, safety monitoring, insurance coverage, and who makes an ideal candidate.
Because chronic fatigue can stem from many overlapping causes—thyroid issues, sleep disorders, autoimmune conditions, or mitochondrial dysfunction—knowing whether NAD+ therapy is right for you starts with understanding your specific symptoms. Take a free, instant, online symptom check to clarify what may be driving your fatigue and confidently plan your next steps.
Reviewed for medical accuracy: 07/09/2026
Why Your Doctor May Prescribe NAD+ for Chronic Fatigue Syndrome
Chronic fatigue syndrome (also known as myalgic encephalomyelitis or ME/CFS) is a complex long-term condition marked by extreme tiredness, sleep disturbances, muscle and joint pain, and difficulty concentrating. While the exact cause remains unclear, research points to mitochondrial dysfunction, oxidative stress, and impaired cellular repair as key factors. As an expert in both medicine and human physiology, here's why your doctor might consider prescribing NAD+ to help manage chronic fatigue syndrome symptoms.
What Is NAD+?
Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme found in every cell of your body. It plays crucial roles in:
As we age or endure prolonged stress, NAD+ levels naturally decline, potentially contributing to fatigue, reduced mental clarity, and slower recovery from illness.
How NAD+ Targets Underlying Factors in ME/CFS
Emerging studies and clinical observations suggest that boosting NAD+ may address several hallmarks of chronic fatigue syndrome:
• Mitochondrial Support
– Low NAD+ impairs mitochondrial ATP production, worsening fatigue.
– Restoring NAD+ can enhance mitochondrial function and energy output.
• Oxidative Stress Reduction
– In ME/CFS, overproduction of reactive oxygen species (ROS) damages cells.
– NAD+ bolsters antioxidant defenses by fueling enzymes like SIRT3, which neutralize ROS.
• DNA Repair and Cellular Resilience
– Accumulated DNA damage from chronic inflammation can exhaust repair mechanisms.
– NAD+ supplementation activates PARP enzymes, aiding in efficient DNA repair.
• Inflammation Modulation
– Chronic inflammation is common in ME/CFS, often driven by dysregulated immune signaling.
– NAD+ influences sirtuins (e.g., SIRT1), which help tone down excessive inflammatory responses.
Clinical Evidence and Ongoing Research
While large-scale randomized controlled trials (RCTs) are still limited, several small studies and case reports highlight potential benefits of NAD+ therapy in fatigue-related disorders:
Experts caution that more robust RCTs are needed to confirm efficacy, determine optimal dosing, and establish long-term safety for people with chronic fatigue syndrome.
Methods of NAD+ Administration
Your doctor will choose a form of NAD+ based on your symptoms, medical history, and practical considerations:
• Intravenous (IV) NAD+
– Delivers high concentrations directly into the bloodstream.
– Often used in supervised clinic settings over multiple sessions.
– May offer quicker symptom relief but can be costly and require travel.
• Oral Precursors (e.g., Nicotinamide Riboside, Nicotinamide Mononucleotide)
– Taken as daily supplements.
– Raise NAD+ more gradually; easier to self-administer.
– Generally well tolerated, with mild digestive upset in some cases.
Your physician will monitor your response, adjust dosage, and watch for side effects such as nausea, headache, or flushing.
Potential Benefits for ME/CFS Patients
Patients report a range of improvements when incorporating NAD+ therapy into a comprehensive treatment plan:
Remember, NAD+ is not a guaranteed cure but may complement other interventions like pacing, cognitive behavioral therapy, graded exercise therapy (if tolerated), and nutritional support.
Risks and Considerations
While generally safe, NAD+ therapy isn't suitable for everyone. Discussion points with your doctor should include:
Your physician will weigh the potential benefits against risks and ensure proper monitoring for adverse events.
Who May Be a Good Candidate?
Your doctor might suggest NAD+ supplementation if you have:
If you're experiencing persistent exhaustion and haven't yet pinpointed the cause, take a moment to check your symptoms with a free AI-powered tool that can help you identify patterns and prepare for a more productive conversation with your healthcare provider about treatments like NAD+ therapy.
Next Steps: Talking to Your Doctor
NAD+ therapy represents a promising avenue but requires careful medical oversight. When you bring this up:
Important Safety Reminder
Nothing in this article replaces personalized medical advice. If you experience sudden, severe, or life-threatening symptoms—such as chest pain, shortness of breath, or severe neurological changes—seek emergency care immediately. Always speak to your doctor before starting or changing any treatment for chronic fatigue syndrome.
By understanding the science behind NAD+ and chronic fatigue syndrome, you can make informed decisions with your healthcare team. Together, you'll develop a plan that balances potential benefits, risks, and your unique needs—paving the way toward better energy, clarity, and quality of life.
(References)
* Yancey JR, Goudie D, Campion E, et al. Treatment with the NAD+ precursor nicotinamide riboside (NR) in a patient with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and co-existing disorders. J Transl Med. 2020 Jan 22;18(1):31. doi: 10.1186/s12967-020-02222-6. PMID: 31969135; PMCID: PMC6975204.
* Camporeale A, Iacobucci R, Nitti P, et al. NAD+ and Mitochondrial Health in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review. Cells. 2022 Jul 25;11(15):2294. doi: 10.3390/cells11152294. PMID: 35892557; PMCID: PMC9330107.
* Nogueira L, Lages S, Brilhante M, et al. Disrupted NAD+ metabolism in ME/CFS: potential for therapeutic intervention. Neurobiol Dis. 2022 Mar;164:105624. doi: 10.1016/j.nbd.2022.105624. Epub 2022 Feb 10. PMID: 35150824.
* Missailidis D, Annesley SJ, Allan M, et al. Mitochondrial dysfunction and its consequences for NAD+ and ATP production are hypothesized to play a crucial role in the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J Transl Med. 2023 Apr 17;21(1):241. doi: 10.1186/s12967-023-04092-2. PMID: 37069695; PMCID: PMC10107297.
* D'Souza R, Singh P, Perlmutter D. Nicotinamide Riboside as a Potential Therapeutic Target for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Clin Exp Neuropsychol. 2022 Jul;44(4):303-313. doi: 10.1080/19398203.2022.2139700. Epub 2022 Nov 3. PMID: 36329759.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.